Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00777855 · ClinicalTrials.gov registry record · NA
Drug Interaction Study of Rifampin and Warfarin in Healthy Volunteers.
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00777855 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 10 participants.
The verdict
NCT00777855, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the importance of uptake drug transporters in the drug disposition of warfarin. We predict that the elimination of warfarin will be decreased when co-dosed with an inhibitor of uptake drug transporters.
Interventions
- DRUG warfarin
- DRUG warfarin plus rifampin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00777855
The ClinicalTrials.gov registry entry for NCT00777855 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which warfarin is the first listed.
NCT00777855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00777855 about?
NCT00777855 is a clinical study titled "Drug Interaction Study of Rifampin and Warfarin in Healthy Volunteers.". The purpose of this study is to determine the importance of uptake drug transporters in the drug disposition of warfarin. We predict that the elimination of warfarin will be decreased when co-dosed with an inhibitor of uptake drug transporters.
What is the current status of trial NCT00777855?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2008-11. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00777855?
The interventions under investigation include: warfarin (DRUG), warfarin plus rifampin (DRUG).
Who is sponsoring clinical trial NCT00777855?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.